Article
Impact of loss-of-function in angiopoietin-like 4 on the human phenome
2024-02-14
Abstract excerpt
<h4>Background</h4> Carriers of the E40K loss-of-function variant in Angiopoietin-like 4 ( ANGPTL4 ), have lower plasma triglyceride levels as well as lower rates of coronary artery disease (CAD) and type 2 diabetes (T2D). These genetic data suggest ANGPTL4 inhibition as a potential therapeutic target for cardiometabolic diseases. However, it is unknown whether the association between E40K and human diseases is du...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2fac0ee5-4588-5ac0-bc68-fd1a4297aabc
- DOI
- 10.1101/2024.02.13.24302776
